BackEdwards Lifesciences Overview
stock.name

Edwards Lifesciences Target Price

Analysts' 12-month price predictions for EW.

Share Price

$84.67

Average Target Price

$102.0020.5% upside

3 analysts in the last 4 months

High: $105 | Low: $100

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2024-04-15RBC CapitalShagun Singh$10119.3% upsideOpen
2024-04-11Mizuho SecuritiesAnthony Petrone$10524% upsideOpen
2024-03-18OppenheimerSuraj Kalia$10018.1% upsideOpen
2023-02-01Truist Financial$861.6% upsideOpen
2023-02-01Canaccord Genuity$7610.2% downsideOpen
2023-01-06Morgan Stanley$9512.2% upsideOpen
2022-12-13Raymond James$832% downsideOpen
2022-12-12Citigroup$928.7% upsideOpen
2022-12-05Stifel NicolausRick Wise$7511.4% downsideOpen
2022-11-28RBC Capital$10524% upsideOpen
2022-10-28RBC CapitalShagun Singh Chadha$11839.4% upsideOpen
2022-07-30Truist FinancialRichard Newitter$12041.7% upsideOpen
2022-04-27Raymond James$12446.5% upsideOpen
2022-04-27Leerink Partners$13863% upsideOpen
2022-04-27RBC Capital$13559.4% upsideOpen
2022-04-27Canaccord Genuity$13761.8% upsideOpen
2022-04-06Evercore ISIVijay Kumar$12648.8% upsideOpen
2022-03-03Bank of America SecuritiesTravis Steed$13053.5% upsideOpen
2022-01-27Morgan StanleyCecilia Furlong$13660.6% upsideOpen
2022-01-27Leerink PartnersDanielle Antalffy$13053.5% upsideOpen
2022-01-27Stifel NicolausRick Wise$12041.7% upsideOpen
2022-01-26Deutsche BankPito Chickering$11333.5% upsideOpen
2022-01-07Credit SuisseMatt Miksic$14065.3% upsideOpen
2021-12-17J.P. MorganRobbie Marcus$14065.3% upsideOpen
2021-12-09Wells FargoLarry Biegelsen$13357.1% upsideOpen
2021-12-09OppenheimerSuraj Kalia$13559.4% upsideOpen
2021-12-09Cowen & Co.Josh Jennings$14065.3% upsideOpen
2021-11-08JefferiesAnthony Petrone$13559.4% upsideOpen